Cardlytics, Inc. Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cardlytics, Inc. (CDLX) (“Cardlytics” or the “Company”) (NASDAQ: CDLX)…. Read MoreJoin Investigation
Dril-Quip, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Dril-Quip, Inc. (“Dril-Quip” or the “Company”)(NYSE: DRQ). Click here to join the investigation…. Read MoreJoin Investigation
The Chemours Company Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation…. Read MoreJoin Investigation
Inari Medical, Inc. Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Inari Medical, Inc. (NasdaqGS: NARI) for an Expanded Class Period—March 10, 2021 through February 28, 2024… Read More
